期刊文献+

载脂蛋白E拟肽对实验性变态反应性脑脊髓炎小鼠基质金属蛋白酶-9和基质金属蛋白酶组织抑制因子-1表达的影响 被引量:5

Effects of Apolipoprotein E-mimetic peptides on the expressions of matrix metalloproteinase-9 and matrix metalloproteinase tissue inhibitor-1 in mice with experimental autoimmune encephalomyelitis
下载PDF
导出
摘要 目的探讨载脂蛋白E(ApoE)拟肽对实验性变态反应性脑脊髓炎(EAE)小鼠基质金属蛋白酶-9(MMP-9)和基质金属蛋白酶组织抑制因子-1(TIMP-1)表达的影响。方法将30只雌性C57BL/6J小鼠随机分为ApoE拟肽组、EAE组和正常组,每组10只小鼠。EAE模型通过以髓鞘少突胶质细胞糖蛋白多肽35-55为抗原诱导。ApoE拟肽组在免疫后第2 d到30 d每隔2 d按5 mg/(kg·d)背部皮下注射Apo E拟肽。EAE组和正常组均以等体积生理盐水替代。免疫后第0-35 d每日对小鼠进行神经功能评分。免疫后第35d解剖小鼠,分离大脑和脊髓并行HE染色。采用免疫组化染色法检测各组小鼠大脑、脑干和脊髓的MMP-9和TIMP-1的表达。结果正常组小鼠均未发病。ApoE拟肽组、EAE组的小鼠全部发病,但各有1只小鼠发病后死亡。ApoE拟肽组与EAE组的发病潜伏期差异无统计学意义(P=0.72)。ApoE拟肽组的神经功能评分在峰值和慢性期(第35 d)均明显低于EAE组(均P〈0.05)。HE染色示,正常组未见炎症细胞浸润;EAE组小鼠大脑、脑干和脊髓均有不同程度的炎性细胞浸润,以脑干和脊髓较为明显;ApoE拟肽组小鼠CNS炎性细胞浸润相对于EAE组明显减少。EAE组小鼠大脑、脑干和脊髓的MMP-9表达均高于正常组(均P〈0.05)。ApoE拟肽组小鼠大脑和脊髓的MMP-9表达要明显低于EAE组(均P〈0.05),其中ApoE拟肽组小鼠中脑和脊髓的MMP-9表达与正常组相比无明显差异(均P〉0.05)。正常组小鼠脊髓TIMP-1的表达明显高于EAE组和Apo E拟肽组(均P〈0.05)。而ApoE拟肽组与EAE组小鼠大脑、脑干和脊髓TIMP-1表达的差异均无统计学意义(均P〉0.05)。结论 ApoE拟肽能通过抑制大脑和脊髓MMP-9的表达改善EAE小鼠的症状。 Objective To explore the effects of Apolipoprotein E-mimetic peptides on the expressions of matrix metalloproteinase-9( MMP-9) and matrix metalloproteinase tissue inhibitor-1( TIMP-1) in mice with experimental autoimmune encephalomyelitis( EAE). Methods Thirty female C57 BL /6J mouse were randomly divided into 3groups: Apo E-mimetic peptides-treated group,EAE group and health group,with 10 mouse in each group. The EAE model was induced in mice using myelin oligodendrocyte glycoprotein peptides 35-55. Apo E-mimetic peptides-treated mice were subcutaneously injected 5 mg /( kg·d) Apo E mimetic peptide every 2 d from immunization 2 d to 30 d.EAE group and normal group replaced with an equal volume of saline injections. The neurological function of mice were scored daily after immunization 0 d to 35 d. Mice were dissected after immunization 35 d,the brain and spinal cord were collected and their expressions of MMP-9 and TIMP-1 were detected using immunohistochemistry. Results The health group had no sick mice. Whole EAE mice were illness in Apo E-mimetic peptides-treated group and EAE group,and the two groups each had a death after the onset. The latency difference between Apo E peptide group and EAE group was not statistically significant( P = 0. 72). The peak and chronic phase( 35 d) neurological scores of Apo E mimetic peptide group were significantly lower than EAE group( all P〈0. 05). HE staining showed normal group had no inflammatory cell infiltration. The brain,brain stem and spinal cord of EAE suffered varying degrees of inflammatory cell infiltration,which was more obvious in brain stem and spinal cord. Apo E peptide-treated group showed significantly reduced CNS inflammatory cell infiltration campared to EAE group. The MMP-9 expression of brain,brain stem and spinal cord in EAE group was significantly higher than health group( all P〈0. 05). The MMP-9 expression of brain and spinal cord in Apo E mimetic peptide group was significantly lower than EAE group( all P〈0. 05),and was not significantly different with the health group( all P〉0. 05). The spinal TIMP-1expression in health group was significantly higher than EAE group and Apo E mimetic peptide group respectively( all P〈0. 05). The brain stem and spinal cord TIMP-1 expression in Apo E peptide group was not statistically different with EAE group( all P〈0. 05). Conclusion Apo E-mimetic peptides can protect against EAE in mice through inhibiting the expression of MMP-9 in brain and spinal cord.
出处 《临床神经病学杂志》 CAS 北大核心 2016年第2期124-127,共4页 Journal of Clinical Neurology
基金 国家自然科学基金项目(81260188 81460194) 广西自然科学基金项目(2012GXNSFAA053082) 广西卫生厅课题(z2012097)
关键词 载脂蛋白E拟肽 实验性变态反应性脑脊髓炎 多发性硬化 金属蛋白酶-9 基质金属蛋白酶组织抑制因子-1 Apolipoprotein E-mimetic peptides experimental autoimmune encephalomyelitis multiple sclerosis matrix metalloproteinase-9 matrix metalloproteinase tissue inhibitor-1
  • 相关文献

参考文献12

  • 1Engelhardt B. The blood-central nervous system barriers activelycontrol immune cell entry into the central nervous system [ J ]. CurrPharm Des, 2008 , 14: 1555.
  • 2Zheng M, Wei J, Tang Y, et al. ApoE-deficient promotes blood-brain barrier disruption in experimental autoimmune encephalomyeli-tis via alteration of MMP-9 [ J ]. J Mol Neurosci, 2014, 54: 282.
  • 3Wu J, Zhao D, Wu S, et al. Ang-( 1 -7) exerts protective role inblood-brain barrier damage by the balance of TIMP-l/MMP-9 [ J].Eur J Pharmacol,2015,748 : 30.
  • 4Hauser PS, Narayanaswami V,Ryan RO. Apolipoprotein E: fromlipid transport to neurobiology [ J ]. Prog Lipid Res, 2011 , 50: 62.
  • 5郑能慆,吴卫平.实验性自身免疫性脑脊髓炎大鼠脊髓载脂蛋白E表达的研究[J].临床神经病学杂志,2013,26(6):430-433. 被引量:1
  • 6韦俊杰,郑明华,梁培霄,陶敏,唐玉兰.载脂蛋白E拟肽对EAE小鼠的髓鞘和轴突损伤的影响[J].中风与神经疾病杂志,2012,29(10):872-875. 被引量:7
  • 7郑明华,唐玉兰,韦俊杰,梁培霄,陶敏,韦云飞.载脂蛋白E拟肽对实验性自身免疫性脑脊髓炎小鼠脑脊髓CD4^+、CD8^+ T淋巴细胞表达的影响[J].临床神经病学杂志,2013,26(3):198-201. 被引量:8
  • 8Wei J, Zheng M,Liang P,et al. Apolipoprotein E and its mimeticpeptide suppress Thl and Thl7 responses in experimental autoim-mune encephalomyelitis[ J] . Neurobiol Dis, 2013 , 56; 59.
  • 9Ram M,Sherer Y,Shoenfeld Y. Matrix metalloproteinase-9 and au-toimmune diseases[ J]. J Clin Immunol, 2006,26: 299.
  • 10Bell RD, Winkler EA, Singh I,et al. Apolipoprotein E controls ce-rebrovascular integrity via cyclophilin A[ J]. Nature, 2012, 485 :512.

二级参考文献40

  • 1Karussis D, Michaelson DM, Grigoriadis N, et al. Lack of apolipopro- tein-E exacerbates experimental allergic encephalomyelitis [ J ]. Muh Scler,2003,9 ( 5 ) :476 - 480.
  • 2Laskowitz DT, Fillit H, Yeung N, et al. Apolipoprotein E-derived pep- tides reduce CNS inflammation: implications for therapy of neur01ogi- cal disease [ J ]. Acta Neurol Scand Suppl, 2006,114 ( suppl 185 ) : 15 -20.
  • 3Weaver A, Goncalves Da Silva A, Nuttall RK, et al. An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Thl/Th2 polarization [ J]. FASEB J,2005,19 (12) :1668 - 1670.
  • 4Li FQ, Sempowski GD, McKenna SE, et al. Apolipoprotein E-derivedpeptides ameliorate clinical disability and inflammatory infiltrates into the spinal corot in a murine model of multiple sclerosis[ J]. J Pharma- col Ep Ther,2006,318 ( 3 ) :956 - 965.
  • 5Gold R, Linington C, Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models : 70 years of merits and culprits in experimental autoimmune encephalomyelitis research [ J ]. Brain,2006,129(8) :1953 - 1971.
  • 6Teunissen CE, Dijkstra C, Polman C. Biological markers in CSF and blood for axonal degeneration in multiple sclerosis[ J ]. Lancet Neurol, 2005,4(1) :32 -41.
  • 7Croy JE,Brandon T,Komives EA. Two apolipoprotein E mimetic pep- tides,ApoE(130-149) and ApoE( 141-155)2,bind to LRP1 [J]. Bio- chemistry., 2004,43 ( 23 ) :7328 - 7335.
  • 8Gauhier A,Wu X,Le Moan N,et al. Low-density lipoprotein reeeptor- related protein 1 is an essential receptor for myelin phagoeytosis [ J ]. J Cell Sei,2009,122(8) :1155 -1162.
  • 9Hayashi H, Campenot RB, Vance DE, et al. Apolipoprotein E-contai- ning lipoproteins protect neurons from apoptosis via a signaling path- way involving low-density lipoprotein receptor-related protein-1 [ J ]. J Neurosci ,2007,27(8) : 1933 - 1941.
  • 10Lynch JR,Tang W,Wang H,et al. APOE genotype and an ApoE-mi- metic peptide modify the systemic and central nervous system inflam- matory response [ J ]. J Biol chem,2003,278 (49) : 48529 - 48533.

共引文献10

同被引文献28

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部